You are here

  • Home
  • Archive
  • Volume 14, Issue Suppl 1
  • TOPOTECAN VERSUS TREOSULFAN IN EARLY RECURRENT OVARIAN CANCER AFTER PRIMARY PLATINUM/ PACLITAXEL CHEMOTHERAPY. A PROSPECTIVE RANDOMIZED PHASE III TRIAL OF THE AGO OVARIAN CANCER STUDY GROUP

Alerts

Article menu
Abstract
Free Communications
TOPOTECAN VERSUS TREOSULFAN IN EARLY RECURRENT OVARIAN CANCER AFTER PRIMARY PLATINUM/ PACLITAXEL CHEMOTHERAPY. A PROSPECTIVE RANDOMIZED PHASE III TRIAL OF THE AGO OVARIAN CANCER STUDY GROUP
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address